A Longitudinal Observational Cohort Study of NSI-189, With Out-Patients With Major Depressive Disorder
Public ClinicalTrials.gov record NCT02724735. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Longitudinal Observational Cohort Study of NSI-189, a Neurogenic Compound Among Out-Patients With Major Depressive Disorder
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
All subjects completing the randomized treatment period in Protocol NS2014-1 will discontinue study drug and be asked to provide consent to be followed in this 6-month study, at their final safety visit. The study will consist of an enrollment visit, followed by bi-monthly in-clinic visits with monthly telephone visits between in-clinic visits.
Study identification
- NCT ID
- NCT02724735
- Recruitment status
- Not listed
- Study type
- Observational
- Phase
- Not listed
- Enrollment
- 220 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years to 61 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jul 31, 2016
- Primary completion
- Nov 30, 2017
- Completion
- Dec 31, 2017
- Last update posted
- Sep 20, 2016
2016 – 2018
United States locations
- U.S. sites
- 12
- U.S. states
- 9
- U.S. cities
- 12
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Not listed | Garden Grove | California | 92845 | Recruiting |
| Not listed | National City | California | 91950 | Recruiting |
| Not listed | Denver | Colorado | 80209 | Recruiting |
| Not listed | Jacksonville | Florida | 32256 | Recruiting |
| Not listed | Orlando | Florida | 32801 | Recruiting |
| Not listed | Alpharetta | Georgia | 30005 | Recruiting |
| Not listed | St Louis | Missouri | 63141 | Recruiting |
| Not listed | Staten Island | New York | 10312 | Recruiting |
| Not listed | Dayton | Ohio | 45417 | Recruiting |
| Not listed | Memphis | Tennessee | 38119 | Recruiting |
| Not listed | Dallas | Texas | 75231 | Recruiting |
| Not listed | San Antonio | Texas | 78229 | Recruiting |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT02724735, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Sep 20, 2016 · Synced Sep 3, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT02724735 live on ClinicalTrials.gov.